Home
>
National Drug Code (NDC)
>
Teveten
Teveten - 0074-3025-11 - (Eprosartan Mesylate)
Drug Information of Teveten
| Product NDC: | 0074-3025 |
| Proprietary Name: | Teveten |
| Non Proprietary Name: | Eprosartan Mesylate |
| Active Ingredient(s): | 400 mg/1 & nbsp; Eprosartan Mesylate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Teveten
| Product NDC: | 0074-3025 |
| Labeler Name: | Abbott Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020738 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100524 |
Package Information of Teveten
| Package NDC: | 0074-3025-11 |
| Package Description: | 100 TABLET in 1 BOTTLE (0074-3025-11) |
NDC Information of Teveten
| NDC Code | 0074-3025-11 |
| Proprietary Name | Teveten |
| Package Description | 100 TABLET in 1 BOTTLE (0074-3025-11) |
| Product NDC | 0074-3025 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Eprosartan Mesylate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100524 |
| Marketing Category Name | NDA |
| Labeler Name | Abbott Laboratories |
| Substance Name | EPROSARTAN MESYLATE |
| Strength Number | 400 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
